The U.S. is recommending a pause in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.
On the CDC website we are shown something called 'Zombie Preparedness', something they say started as 'a tongue-in-cheek campaign to engage new audiences with preparedness messages has proven to be a very effective platform.' Can someone please tell me where I can find the humor in hundreds of thousands of adverse reactions and hundreds of fatalities already as a result of the COVID-19 vaccine? Looks like people are actually turning into zombies, there is death in the pot!
"So they poured out for the men to eat. And it came to pass, as they were eating of the pottage, that they cried out, and said, O thou man of God, there is death in the pot. And they could not eat thereof." 2 Kings 4:40 (KJB)
Another way the CDC lies to you is how they tabulate vaccine reactions. You will recall last year when Dr. Birx infamously remarked that anyone with a previous medical condition who also had COVID when they died would be marked as a 'COVID death'. She meant that if someone died of cancer or a heart attack while COVID positive, it would be a COVID death. Well, they use the reverse with vaccine reactions. Anyone who dies after receiving the COVID jab is automatically reported as 'no known connection' between their death and the vaccine. This way, the numbers of COVID deaths is inflated and the number of vaccine fatalities is reduced by their duplicitous creative accounting. They are lying to us on every level, and it sure looks like they are reaching their stated 'tongue-in-cheek' goal of zombie preparedness.
US recommends ‘pause’ for J&J vaccine over clot reports
FROM AP: In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigating unusual clots in six women that occurred 6 to 13 days after vaccination. The clots occurred in veins that drain blood from the brain and occurred together with low platelets. All six cases were in women between the ages of 18 and 48.
The reports appear similar to a rare, unusual type of clotting disorder that European authorities say is possibly linked to another COVID-19 vaccine not yet cleared in the U.S., from AstraZeneca. More than 6.8 million doses of the J&J vaccine have been administered in the U.S., the vast majority with no or mild side effects.
U.S. federal distribution channels, including mass vaccination sites, will pause the use of the J&J shot, and states and other providers are expected to follow. The other two authorized vaccines, from Moderna and Pfizer, make up the vast share of COVID-19 shots administered in the U.S. and are not affected by the pause.
CDC’s Advisory Committee on Immunization Practices will meet Wednesday to discuss the cases and the FDA has also launched an investigation into the cause of the clots and low platelet counts.
“Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,” Dr. Anne Schuchat, principal deputy director of the CDC, and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a joint statement.
They are recommending that people who were given the J&J vaccine who are experiencing severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after receiving the shot contact their health care provider.
U.S. health authorities cautioned doctors against using a typical clot treatment, the blood-thinner heparin. “In this setting, administration of heparin may be dangerous and alternative treatments need to be given,” the FDA and CDC said. European authorities investigating the AstraZeneca cases have concluded clots appear to be similar to a very rare abnormal immune response that sometimes strikes people treated with heparin, leading to a temporary clotting disorder. Officials say they also want to educate vaccine providers and health professionals about the “unique treatment” required for this type of clot.
Johnson & Johnson said it was aware of the reports of “thromboembolic events,” or blood clots, but that no link to its vaccine had been established.
“We are aware that thromboembolic events including those with thrombocytopenia have been reported with Covid-19 vaccines,” said Johnson & Johnson in a statement. “At present, no clear causal relationship has been established between these rare events and the Janssen Covid-19 vaccine.” READ MORE
No comments:
Post a Comment